Therefore, we asked whether the expression levels of Dicer could vary during breast cancer progression both at the transcriptional and post-transcriptional levels, as has been shown in ovarian, lung, and prostate cancers (Chiosea et al, 2006, 2007; Flavin et al, 2008; Merritt et al, 2008). Here, DICER1 is linked to breast cancer.